These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 5424406)

  • 1. [Clinical trial of a delayed-action preparation of beta pyridyl-carbinol in vascular pathology].
    Warembourg H; Thery C
    Lille Med; 1970 Apr; 15(4 Suppl 3):599-602. PubMed ID: 5424406
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnosis and therapy of peripheral disorders of the blood circulation with special consideration of the effect of beta pyridyl carbinol].
    Broghammer H
    Med Welt; 1967 Apr; 17():1091-100. PubMed ID: 5586962
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of nicotinyl alcohol in delayed-action form in some obstetrical gynecological vascular diseases].
    De Marini M
    Minerva Ginecol; 1969 Jan; 21(2):63-6. PubMed ID: 5776754
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical study of beta-pyridyl carbinol (Ronicol Timespan)].
    Kobayashi K; Shibata M; Kato K; Kawaguchi S; Sasa R
    Saishin Igaku; 1969 Dec; 24(12):2530-4. PubMed ID: 5363412
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experiences on the treatment of cerebral insufficiency and peripheral circulation disorders with the test preparation EP 50-100].
    Bock KJ
    Med Welt; 1972 Feb; 23(8):273-5. PubMed ID: 5012543
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the use of an arterial wall extract (Liovasal) in the therapy of some retinal vascular diseases].
    Vitali G; Deledda MG
    Ann Ottalmol Clin Ocul; 1967 Dec; 93(12):1413-29. PubMed ID: 5605996
    [No Abstract]   [Full Text] [Related]  

  • 7. [The treatment of states of failure due to cerebral atrophy with beta-pyridyl-carbinol (Ronicol)].
    Oesterreich K; Tellenbach H
    Nervenarzt; 1967 Jan; 38(1):34-6. PubMed ID: 6047731
    [No Abstract]   [Full Text] [Related]  

  • 8. [A delayed-action therapeutic agent in chronic cerebral circulatory insufficiencies].
    Boudouresques J; Papy JJ; Daniel F
    Therapeutique; 1970 Oct; 46(8):789-92. PubMed ID: 5458910
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical trial of a long-acting vasodilator agent in chronic peripheral obliterating arteriopathy of a sclerotic nature].
    Gemma GB; Ghezzi P; Cavaliere P
    Minerva Cardioangiol; 1969 May; 17(5):324-32. PubMed ID: 5785730
    [No Abstract]   [Full Text] [Related]  

  • 10. [Value of drugs acting on the smooth musculature by direct and indirect routes in therapy of vascular diseases].
    Labò G; Pretolani E
    Cardiol Prat; 1971 Feb; 22(1):1-9. PubMed ID: 4398064
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical considerations on the use of a drug with vasodilating hemokinetic action in cerebral and peripheral vascular diseases].
    Florio F; Ruffolo S; Piro E
    Minerva Cardioangiol; 1976 Feb; 24(2):161-70. PubMed ID: 1256656
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical trial of Nicametate in vascular pathology].
    Langeron P
    J Sci Med Lille; 1972 Apr; 90(4):179-82. PubMed ID: 5079565
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of arterial blood circulatory disorders associated with predominantly autonomic vascular syndrome].
    Lier G
    Munch Med Wochenschr; 1968 Feb; 110(5):292-4. PubMed ID: 5695078
    [No Abstract]   [Full Text] [Related]  

  • 14. [Raubasine in arterial pathology of the extremities].
    Perrin M
    Lyon Med; 1965 May; 213(21):1585-90. PubMed ID: 5828799
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of the therapeutic activity of the beta-pyridyl-carbinolic ester of clofibric acid].
    Silingardi V; Renzi R; Mora A; Di Prisco AU
    Minerva Med; 1973 Mar; 64(16):751-69. PubMed ID: 4579325
    [No Abstract]   [Full Text] [Related]  

  • 16. [Measurements of various circulatory parameter and muscle blood flow of the leg in patients with blood circulation disorders after intravenous infusion of beta-pyridyl-carbinol (Ronicol)].
    Broghammer H; Guckenbiehl W
    Med Klin; 1968 May; 63(20):797-803. PubMed ID: 5706576
    [No Abstract]   [Full Text] [Related]  

  • 17. [New chemical substances for therapeutic use].
    Clin Ter; 1970 Mar; 52(6):571-4. PubMed ID: 5452999
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical use of 53-14 C in the treatment of arteritis of the lower limbs].
    Warembourg H; Peltier JM
    Lille Med; 1971; 16(7):Suppl 3:917-21. PubMed ID: 5118954
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action of MD 1035 in peripheral vascular manifestations].
    Barraine R; Efthymiou TP; Marcantoni JP
    Presse Med (1893); 1970 Dec; 78(53):2389-90. PubMed ID: 5489156
    [No Abstract]   [Full Text] [Related]  

  • 20. [Further trials of a long-acting vasodilator agent in 397 patients with cronic peripheral obliterating arteriopathy of a sclerotic nature].
    Ghezzi P; Cavaliere P; Berti Riboli E
    Minerva Cardioangiol; 1969 May; 17(5):333-6. PubMed ID: 5785731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.